Endymed Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Endymed.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Medical Equipment earnings growth | 22.3% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Endymed Ltd's (TLV:ENDY) Share Price Boosted 43% But Its Business Prospects Need A Lift Too
Nov 07Endymed Ltd's (TLV:ENDY) 25% Dip In Price Shows Sentiment Is Matching Revenues
Sep 23Endymed Ltd (TLV:ENDY) Investors Are Less Pessimistic Than Expected
Aug 06Here's What's Concerning About Endymed's (TLV:ENDY) Returns On Capital
May 24Endymed Ltd's (TLV:ENDY) Share Price Not Quite Adding Up
Mar 11Endymed (TLV:ENDY) Is Looking To Continue Growing Its Returns On Capital
Oct 23We Like These Underlying Return On Capital Trends At Endymed (TLV:ENDY)
Jul 17Returns Are Gaining Momentum At Endymed (TLV:ENDY)
Apr 03Endymed's (TLV:ENDY) Returns On Capital Are Heading Higher
Nov 18We Like These Underlying Return On Capital Trends At Endymed (TLV:ENDY)
Jun 03Endymed (TLV:ENDY) Is Doing The Right Things To Multiply Its Share Price
Feb 13Here's Why We Think Endymed (TLV:ENDY) Is Well Worth Watching
Nov 28Endymed (TLV:ENDY) Is Experiencing Growth In Returns On Capital
Oct 31Is Now The Time To Put Endymed (TLV:ENDY) On Your Watchlist?
Aug 29Investors Will Want Endymed's (TLV:ENDY) Growth In ROCE To Persist
Aug 01We Like These Underlying Return On Capital Trends At Endymed (TLV:ENDY)
Apr 11Endymed Ltd's (TLV:ENDY) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Feb 15Returns On Capital - An Important Metric For Endymed (TLV:ENDY)
Jan 10Should You Use Endymed's (TLV:ENDY) Statutory Earnings To Analyse It?
Dec 14In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Endymed has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
9/30/2024 | 19 | -2 | -2 | -2 | N/A |
6/30/2024 | 20 | -1 | -3 | -3 | N/A |
3/31/2024 | 21 | 0 | -3 | -3 | N/A |
12/31/2023 | 23 | 1 | -1 | -1 | N/A |
9/30/2023 | 23 | 1 | -1 | -1 | N/A |
6/30/2023 | 22 | 1 | 0 | 0 | N/A |
3/31/2023 | 22 | 1 | 0 | 0 | N/A |
12/31/2022 | 21 | 1 | 0 | 0 | N/A |
9/30/2022 | 22 | 3 | 1 | 1 | N/A |
6/30/2022 | 23 | 4 | 0 | 0 | N/A |
3/31/2022 | 24 | 5 | 3 | 4 | N/A |
12/31/2021 | 22 | 5 | 5 | 5 | N/A |
9/30/2021 | 20 | 2 | 4 | 4 | N/A |
6/30/2021 | 19 | 2 | 7 | 7 | N/A |
3/31/2021 | 16 | 1 | 3 | 3 | N/A |
12/31/2020 | 14 | 0 | 1 | 1 | N/A |
9/30/2020 | 14 | 1 | 2 | 2 | N/A |
6/30/2020 | 14 | 1 | 1 | 1 | N/A |
3/31/2020 | 15 | 2 | 1 | 2 | N/A |
12/31/2019 | 16 | 2 | 1 | 1 | N/A |
9/30/2019 | 18 | 2 | 1 | 1 | N/A |
6/30/2019 | 18 | 2 | 0 | 0 | N/A |
3/31/2019 | 18 | 2 | 0 | 0 | N/A |
12/31/2018 | 18 | 2 | 1 | 1 | N/A |
9/30/2018 | 18 | 0 | 0 | 0 | N/A |
6/30/2018 | 19 | -1 | N/A | 3 | N/A |
3/31/2018 | 18 | -1 | N/A | 2 | N/A |
12/31/2017 | 18 | -3 | N/A | 0 | N/A |
9/30/2017 | 18 | -3 | N/A | 1 | N/A |
6/30/2017 | 17 | -2 | N/A | -1 | N/A |
3/31/2017 | 15 | -3 | N/A | 0 | N/A |
12/31/2016 | 14 | -3 | N/A | -1 | N/A |
9/30/2016 | 13 | -4 | N/A | -2 | N/A |
6/30/2016 | 12 | -5 | N/A | -4 | N/A |
3/31/2016 | 13 | -4 | N/A | -6 | N/A |
12/31/2015 | 13 | -4 | N/A | -5 | N/A |
9/30/2015 | 13 | -2 | N/A | -5 | N/A |
6/30/2015 | 13 | 0 | N/A | -4 | N/A |
3/31/2015 | 12 | 0 | N/A | -3 | N/A |
12/31/2014 | 11 | 0 | N/A | -3 | N/A |
9/30/2014 | 8 | 0 | N/A | -2 | N/A |
6/30/2014 | 7 | -1 | N/A | -1 | N/A |
3/31/2014 | 7 | -1 | N/A | 0 | N/A |
12/31/2013 | 6 | 0 | N/A | 0 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if ENDY's forecast earnings growth is above the savings rate (2.5%).
Earnings vs Market: Insufficient data to determine if ENDY's earnings are forecast to grow faster than the IL market
High Growth Earnings: Insufficient data to determine if ENDY's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if ENDY's revenue is forecast to grow faster than the IL market.
High Growth Revenue: Insufficient data to determine if ENDY's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if ENDY's Return on Equity is forecast to be high in 3 years time